Publications » 2011

  • J Genet Syndr Gene Ther S1:005, November 18, 2011.Hemophilia: genetics, diagnosis and management.Jayandharan GR, Srivastava A.
  • Front Microbiol. Epub 2011 Sep 19.Innate Immune Responses to AAV Vectors. Rogers GL, Martino AT, Aslanidi GV, Jayandharan GR, Srivastava A, Herzog RW.
  • ProcNatlAcadSci U S A. 2011 Mar 1;108(9):3743-8. Epub 2011 Feb 14. Activation of the NF-kappaB pathway by adeno-associated virus (AAV) vectors and its implications in immune response and gene therapy. Jayandharan GR, Aslanidi G, Martino AT, Jahn SC, Perrin GQ, Herzog RW, Srivastava A.
  • Hum Gene Ther. 2011 May;22(5):633-40. A simple method to increase the transduction efficiency of single-stranded adeno-associated virus vectors in vitro and in vivo. Ma W, Li B, Ling C, Jayandharan GR, Srivastava A, Byrne BJ.
  • MolTher.2011 Feb;19(2):293-301. Epub 2010 Nov 2. Novel properties of tyrosine-mutant AAV2 vectors in the mouse retina. Petrs-Silva H, Dinculescu A, Li Q, Deng WT, Pang JJ, Min SH, Chiodo V, Neeley AW, Govindasamy L, Bennett A, Agbandje-McKenna M, Zhong L, Li B, Jayandharan GR, Srivastava A, Lewin AS, Hauswirth WW.
  • Clin Cancer Res. 2011 Jun 1;17(11):3638-48. Epub 2011 Apr 1. PDGF-D improves drug delivery and efficacy via vascular normalization, but promotes lymphatic metastasis by activating CXCR4 in breast cancer. Liu J, Liao S, Huang Y, Samuel R, Shi T, Naxerova K, Huang P, Kamoun W, Jain RK, Fukumura D, Xu L.